Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.
NYS Entity Status
NYS Filing Date
AUGUST 15, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2013 - M & R CONCESSIONS LLC
Around the Web
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- Here’s How Georgetown Convinced Nike To Make A Major Concession On Workers’ Rights
By Elizabeth Segran - Wednesday Aug 30, 2017
Georgetown ended its contract with Nike amid student protests about labor violations. Today, the two parties announced a new deal that could be a model for other colleges.
For months, students around the country have been putting pressure on their universities to cut ties with Nike over what they describe as unfair labor practices at the company’s factories in Asia.
- DataCamp Nabs $4M for Data Science Courses, Moves to NY
By Jeff Engel - Thursday Jul 27, 2017
Data scientists remain in high demand. But these days, many types of professionals can boost their career prospects if they have at least a basic level of “data literacy,” says Jonathan Cornelissen. That’s part of the reason why he says his online education company, DataCamp, has been growing over the past couple of years. DataCamp, […]
- 'NY Times' Finally Joins Snapchat Discover
Monday Apr 24, 2017
Does The New York Times joining Snapchat Discover lend an air of respectability to a new platform, and breathe new life into an aging publisher? That's obviously what the partners are planning -- butonly time will tell.
- IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
By Ben Fidler - Thursday Aug 3, 2017
Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]